GLOW — Vial
Multikomponenten-Forschungssubstanz: GHK-Cu (50 mg, CAS 89030-95-5), BPC-157 (10 mg, CAS 137525-51-0) und TB-500/Thymosin-β4-Fragment (10 mg). In der Grundlagenforschung zu Kupferpeptid-Aktivität, Gewebeprotektion und extrazellulärer Matrixreparatur untersucht. Ausschließlich für wissenschaftliche Forschung — nicht zur Anwendung am Menschen.
Contents: 1 × lyophilized peptide powder + 1 × bacteriostatic water (3 ml, Bac Water) for reconstitution. The bacteriostatic water is intended as a solvent for reconstituting the lyophilized peptide and is intended for research purposes only.
Free shipping from 199 €
Shipped from the EU (Czech Republic)
External reports for the tested samples (opens at Janoshik). More under Test reports.
FOR RESEARCH USE ONLY. This product is intended exclusively for laboratory and research purposes. Not for human or animal consumption, not a medicinal product or food.
GLOW is a lyophilized multi-component research compound that combines three peptides extensively studied in basic research in a single preparation: GHK-Cu (glycyl-L-histidyl-L-lysine copper, 50 mg), BPC-157 (Body Protection Compound, 15 amino acids, 10 mg) and TB-500 (acetylated thymosin β4 fragment Ac-LKKTETQ, amino acids 17–23, 10 mg).
Forschungsrelevanz der Einzelkomponenten
GHK-Cu (50 mg): In 2018, Pickart and Margolina described in the International Journal of Molecular Sciences (DOI: 10.3390/ijms19071987) transkriptomische Befunde zur Expression von über 4.000 humanen Genen durch GHK-Cu, darunter Gene der Kollagen-I/III-Biosynthese und antioxidativer Schutzmechanismen.
BPC-157 (10 mg): Sikirić et al. beschreiben in mehreren präklinischen Arbeiten (u. a. Current Pharmaceutical Design, 2018, DOI: 10.2174/1381612824666180327110803) gastrointestinal abgeleitetes Pentadecapeptid BPC-157 im Kontext von Gewebeschutz und Gefäßreaktion in Tiermodellen. Humane Studien fehlen zum jetzigen Zeitpunkt weitgehend.
TB-500/Thymosin-β4-Fragment (10 mg): Goldstein und Kleinman publizierten Befunde zur Rolle von Thymosin-β4 in der Aktin-Sequestration und Geweberemodellierung (Ann N Y Acad Sci, 2015, DOI: 10.1111/nyas.12843). TB-500 refers to the acetylated fragment Ac-LKKTETQ (amino acids 17–23), which contains the actin-binding region of thymosin β4.
Compound characterization
- Komponente 1: GHK-Cu · CAS 89030-95-5 · 50 mg · Tripeptid-Kupferkomplex
- Komponente 2: BPC-157 · CAS 137525-51-0 · 10 mg · Pentadecapeptid
- Komponente 3: TB-500/Thymosin-β4-Fragment · 10 mg · Actin-bindendes Peptid
- Physical state: Lyophilized powder (freeze-dried)
- Storage: −20 °C, lichtgeschützt; nach Rekonstitution 2–8 °C
- Contents: 1 × lyophilisiertes Pulver + 1 × Bakteriostatisches Wasser (3 ml)
In the Vial, the substance is supplied as a lyophilized (freeze-dried) powder. Storage recommendation before dissolution: −20 °C, protected from light. Included: 3 ml bacteriostatic water as a solvent for laboratory work.
Solvent, volume, and storage after dissolution are defined in the respective study protocol.
| Name | GLOW — Vial |
| Format | Vial – lyophilized powder |
| Analysis reports | 4 × Janoshik Analytical (linked) |
| SKU | SP-GLOW-VIAL |
| Storage recommendation | −20 °C, protected from light |
Questions about GLOW — Vial
Yes – 4 analysis reports from Janoshik Analytical (HPLC/MS) are linked on this page. They refer to the specific sample tested.
Freeze-drying — the substance is supplied as a powder in the Vial and is dissolved in the lab. 3 ml bacteriostatic water is included.
Shipped within 24–48 hours after receipt of payment from the EU in neutral packaging — to 25 EU countries.
Exclusively for researchers and laboratory users. Not for human or veterinary use, not as a medicinal product, food, or cosmetic.
